The quality of chemotherapy and its quality assurance

European Journal of Surgical Oncology

Volumn 31, Issue 6 SPEC. ISS., 2005, Pages 656-666

  Ottevanger, P B ^a   De Mulder, P H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Daily practice; Quality; Quality assurance; Trials

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

AGE; ARTICLE; BONE MARROW TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER REGISTRY; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; COMORBIDITY; DRUG DOSE REGIMEN; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; MEDICAL AUDIT; MEDICAL LITERATURE; MEDICAL PARAMETERS; MEDLINE; METASTASIS; NEUTROPENIA; OUTCOMES RESEARCH; OVARY CANCER; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; SOCIAL CLASS; SOCIAL STATUS; TESTIS CANCER; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 22144489538     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.02.019     Document Type: Article

References (67)

1. B. Fisher J. Bryant N. Wolmark E. Mamounas A. Brown E.R. Fisher et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 8 1998 2672-2685
2. J.A. Roth H.I. Pass M.M. Flanagan G.M. Graeber J.C. Rosenberg S. Steinberg Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus J Thorac Cardiovasc Surg 96 2 1988 242-248
3. A. Depierre V. Westeel Overview of the role of neoadjuvant chemotherapy for early stage non-small cell lung cancer Semin Oncol 28 4 Suppl 14 2001 29-36
4. C.G. Moertel T.R. Fleming J.S. Macdonald D.G. Haller J.A. Laurie P.J. Goodman et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 6 1990 352-358
5. Early Breast Cancer Trialists' Collaborative Group Polychemotherapy for early breast cancer: An overview of the randomised trials Lancet 352 9132 1998 930-942
6. R. Fossati C. Confalonieri V. Torri E. Ghislandi A. Penna V. Pistotti et al. Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31,510 women J Clin Oncol 16 10 1998 3439-3460
7. J.M. Nabholtz C. Falkson D. Campos J. Szanto M. Martin S. Chan et al. Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: Results of a randomized, multicenter, phase III trial J Clin Oncol 21 6 2003 968-975
8. J.F. Bishop J. Dewar G.C. Toner J. Smith M.H. Tattersall I.N. Olver et al. Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer J Clin Oncol 17 8 1999 2355-2364
9. P.C. Simmonds Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group BMJ 321 7260 2000 531-535
10. J. Wils The treatment of advanced gastric cancer Semin Oncol 23 3 1996 397-406
11. F.A. Shepherd F.V. Fossella T. Lynch J.P. Armand J.R. Rigas M.G. Kris Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials Semin Oncol 28 1 Suppl 2 2001 4-9
12. F.V. Fossella Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials Semin Oncol 26 5 Suppl 16 1999 17-23
13. D.G. Skinner J.R. Daniels C.A. Russell G. Liekovsky S.D. Boyd P. Nichols et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial J Urol 145 3 1991 459-464
14. K. Vantongelen W. Steward G. Blackledge J. Verweij A. Van Oosterom EORTC joint ventures in quality control: Treatment-related variables and data acquisition in chemotherapy trials Eur J Cancer 27 2 1991 201-207
15. W.P. Steward K. Vantongelen J. Verweij D. Thomas A.T. van Oosterom Chemotherapy administration and data collection in an EORTC collaborative group - can we trust the results? Eur J Cancer 29A 7 1993 943-947
16. G. Favalli J.B. Vermorken K. Vantongelen J. Renard A.T. van Oosterom S. Pecorelli Quality control in multicentric clinical trials. An experience of the EORTC Gynecological Cancer Cooperative Group Eur J Cancer 36 9 2000 1125-1133
17. J. Verweij O.S. Nielsen P. Therasse A.T. van Oosterom The use of a systemic therapy checklist improves the quality of data acquisition and recording in multicentre trials. A study of the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer 33 7 1997 1045-1049
18. R.B. Weiss N.J. Vogelzang B.A. Peterson L.C. Panasci J.T. Carpenter M. Gavigan et al. A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B JAMA 270 4 1993 459-464
19. G. Bonadonna P. Valagussa A. Moliterni M. Zambetti C. Brambilla Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up N Engl J Med 332 14 1995 901-906
20. M. Lise D. Nitti A. Marchet T. Sahmoud M. Buyse N. Duez et al. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer J Clin Oncol 13 11 1995 2757-2763
21. D.P. Kelsen R. Ginsberg T.F. Pajak D.G. Sheahan L. Gunderson J. Mortimer et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 27 1998 1979-1984
22. L. Collette R.J. Sylvester S.P. Stenning S.D. Fossa G.M. Mead R. de Wit Impact of the treating institution on survival of patients with 'poor-prognosis' metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party J Natl Cancer Inst 91 10 1999 839-846
23. D.R. Budman D.A. Berry C.T. Cirrincione I.C. Henderson W.C. Wood R.B. Weiss et al. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B [see comments] J Natl Cancer Inst 90 16 1998 1205-1211
24. L.L. Kjaergard B. Als-Nielsen Association between competing interests and authors' conclusions: Epidemiological study of randomised clinical trials published in the BMJ BMJ 325 7358 2002 249
25. A.M. Chouillet C.M.J. Bell J.G. Hiscox Management of breast cancer in southeast England BMJ 308 6922 1994 168-171
26. M. Ma J. Bell S. Campbell I. Basnett A. Pollock I. Taylor Breast cancer management: Is volume related to quality? Clinical Advisory Panel Br J Cancer 75 11 1997 1652-1659
27. R. Sainsbury B. Haward L. Rider C. Johnston C. Round Influence of clinician workload and patterns of treatment on survival from breast cancer Lancet 345 8960 1995 1265-1270
28. P.B. Ottevanger C.A. Verhagen L.V. Beex Quality of adjuvant chemotherapy in primary breast cancer in a non-trial setting. A comprehensive cancer centre study. The Breast Cancer Group of the Dutch Comprehensive Cancer Centre East (IKO) Eur J Cancer 35 3 1999 386-391
29. P.B. Ottevanger P.H. De Mulder R.P. Grol H. Van Lier L.V. Beex Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients Eur J Cancer 40 2 2004 198-204
30. G. Chaplain B. Coudert C. Milan T. Altwegg J. Esteve Changing practice in systemic breast cancer adjuvant treatment in a well-defined French population Bull Cancer 86 10 1999 855-860
31. J. Engel G. Nagel E. Breuer C. Meisner U.S. Albert K. Strelocke et al. Primary breast cancer therapy in six regions of Germany Eur J Cancer 38 4 2002 578-585
32. B.E. Hillner M.K. McDonald L. Penberthy C.E. Desch T.J. Smith P. Maddux et al. Measuring standards of care for early breast cancer in an insured population J Clin Oncol 15 4 1997 1401-1408
33. X. Du J.S. Goodwin Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996 Cancer 92 4 2001 730-737
34. A. Olivotto A.J. Coldman T.G. Hislop C.H. Trevisan J. Kula V. Goel et al. Compliance with practice guidelines for node-negative breast cancer J Clin Oncol 15 1 1997 216-222
35. N. Hebert-Croteau J. Brisson J. Latreille C. Blanchette L. Deschenes Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994 CMAJ 161 8 1999 951-955
36. N. Hebert-Croteau J. Brisson J. Latreille C. Blanchette L. Deschenes Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women Cancer 85 5 1999 1104-1113
37. P.A. Newcomb P.P. Carbone Cancer treatment and age: Patient perspectives J Natl Cancer Inst 85 19 1993 1580-1584
38. J.M. Parry S. Collins J. Mathers N.A. Scott C.B. Woodman Influence of volume of work on the outcome of treatment for patients with colorectal cancer Br J Surg 86 4 1999 475-481
39. A. Grothey L. Kellermann H.J. Schmoll Deficits in management of patients with colorectal carcinoma in Germany. Results of multicenter documentation of therapy algorithms Med Klin (Munich) 97 5 2002 270-277
40. J.Z. Ayanian A.M. Zaslavsky C.S. Fuchs E. Guadagnoli C.M. Creech R.D. Cress et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort J Clin Oncol 21 7 2003 1293-1300
41. D. Schrag L.D. Cramer P.B. Bach C.B. Begg Age and adjuvant chemotherapy use after surgery for stage III colon cancer J Natl Cancer Inst 93 11 2001 850-857
42. A.I. Neugut A.T. Fleischauer V. Sundararajan N. Mitra D.F. Heitjan J.S. Jacobson et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: A population-based study J Clin Oncol 20 11 2002 2643-2650
43. E.J. Junor D.J. Hole C.R. Gillis Management of ovarian cancer: Referral to a multidisciplinary team matters Br J Cancer 70 1 1994 363-370
44. C.D. Wolfe K. Tilling K.S. Raju Management and survival of ovarian cancer patients in south east England Eur J Cancer 33 11 1997 1835-1840
45. K.A. Munoz L.C. Harlan E.L. Trimble Patterns of care for women with ovarian cancer in the United States J Clin Oncol 15 11 1997 3408-3415
46. L.C. Harlan L.X. Clegg E.L. Trimble Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States J Clin Oncol 21 18 2003 3488-3494
47. V. Sundararajan D. Hershman V.R. Grann J.S. Jacobson A.I. Neugut Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: A population-based study J Clin Oncol 20 1 2002 173-178
48. R.D. Cress C.D. O'Malley G.S. Leiserowitz S.L. Campleman Patterns of chemotherapy use for women with ovarian cancer: A population-based study J Clin Oncol 21 8 2003 1530-1535
49. L. Radbruch F. Nauck M. Fuchs K. Neuwohner D. Schulenberg G. Lindena What is palliative care in Germany? Results from a representative survey J Pain Symptom Manage 23 6 2002 471-483
50. G. Macquart-Moulin P. Viens M.L. Bouscary D. Genre M. Resbeut G. Gravis et al. Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: An issue for quality of care Br J Cancer 76 12 1997 1640-1645
51. G.H. Lyman D.C. Dale J. Crawford Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices J Clin Oncol 21 24 2003 4524-4531
52. D.A. Cameron C. Massie G. Kerr R.C. Leonard Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer Br J Cancer 89 10 2003 1837-1842
53. T.J. Iwashyna E.B. Lamont Effectiveness of adjuvant fluorouracil in clinical practice: A population-based cohort study of elderly patients with stage III colon cancer J Clin Oncol 20 19 2002 3992-3998
54. P. Ottevanger L. Beex R. Grol P. De Mulder Quality of chemotherapy for malignant epithelial ovarian carcinoma in a non-trial setting Eur J Cancer 35 Suppl 4 1999 S238-S239
55. P.B. Ottevanger P.H. De Mulder R.P. Grol H. Van Lier L.V. Beex Effects of quality of treatment on prognosis in primary breast cancer patients treated in daily practice Anticancer Res 22 1A 2002 459-465
56. S.H. Woolf R. Grol A. Hutchinson M. Eccles J. Grimshaw Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines BMJ 318 7182 1999 527-530
57. J.M. Grimshaw I.T. Russell Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations Lancet 342 8883 1993 1317-1322
58. T.J. Smith B.E. Hillner Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways J Clin Oncol 19 11 2001 2886-2897
59. R. Grilli G. Apolone S. Marsoni A. Nicolucci P. Zola A. Liberati The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy Med Care 29 1 1991 50-63
60. N. Freemantle R. Grilli J. Grimshaw A. Oxman Implementing findings of medical research: The Cochrane Collaboration on Effective Professional Practice Qual Health Care 4 1 1995 45-47
61. R. Grol J. Dalhuijsen S. Thomas C. Veld G. Rutten H. Mokkink Attributes of clinical guidelines that influence use of guidelines in general practice: Observational study BMJ 317 7162 1998 858-861
62. I. Ray-Coquard T. Philip G. de Laroche X. Froger J.P. Suchaud A. Voloch et al. A controlled 'before-after' study: Impact of a clinical guidelines programme and regional cancer network organization on medical practice Br J Cancer 86 3 2002 313-321
63. K. Calman D. Hine A policy framework for commissioning cancer services: a report by the expert advisory group on cancer to the chief medical officers of England and Wales vol. 34 1995 Department of Health London
64. R. Grilli S. Minozzi A. Tinazzi R. Labianca T.A. Sheldon A. Liberati Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients Ann Oncol 9 4 1998 365-374
65. B.E. Hillner T.J. Smith C.E. Desch Hospital and physician volume or specialization and outcomes in cancer treatment: Importance in quality of cancer care J Clin Oncol 18 11 2000 2327-2340
66. E. Pitchforth E. Russell P.M. Van der Access to specialist cancer care: is it equitable? Br J Cancer 87 11 2002 1221-1226
67. N.C. Campbell A.M. Elliott L. Sharp L.D. Ritchie J. Cassidy J. Little Impact of deprivation and rural residence on treatment of colorectal and lung cancer Br J Cancer 87 6 2002 585-590